HER2/neu over-expression induces endothelial cell retraction

International Journal of Cancer

Volumn 91, Issue 3, 2001, Pages 295-299

  Bradford Carter, W ^a   Hoying, James B ^b   Boswell, Carl ^c   Williams, Stuart K ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Breast carcinoma; HER2 neu over expression; Metastasis

Indexed keywords

NEU DIFFERENTIATION FACTOR;

ARTICLE; BREAST CANCER; CELL ADHESION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; ONCOGENE NEU; PRIORITY JOURNAL; REGULATORY MECHANISM; SHEAR STRESS; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; FEMALE; GENES, ERBB-2; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0035254990     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1061>3.0.CO;2-Y     Document Type: Article

References (28)

1. Prognostic indicators in early breast cancer
2. The fine structure of neoplastic invasion: Invasion of liver, skeletal muscle and lymphatic vessels by the Rd/3 tumor
3. Endothelial injury causes degradation of adjacent basement membranes and promotes their invasion by A549 carcinoma cells
4. Interactions of tumor cells with vascular endothelial monolayers: A model for metastatic invasion
5. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix
6. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
7. Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer
8. Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer: The influence of the pattern of immunostaining and adjuvant therapy
9. The erbB3 gene product is a receptor for heregulin
10. Heregulin induces tyrosine phosphorylation of HER4/ p180erbB4
11. Single-chain antibody-mediated intracellular retention of erbB-2 impairs neu differentiation factor and epidermal growth factor signaling
12. ErbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling
13. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer
14. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness
15. erbB2
16. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
17. p185neu expression in human lung adenocarcinomas predicts shortened survival
18. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the anti-tumor activity of paclitaxel and doxorubicin against HER2/neu over-expressing human breast cancer xenografts
19. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells
20. Human adult endothelial cell growth in culture
21. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
22. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength
23. Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers
24. Enhancement of in vitro tumor-cell transcellular migration by tumor-cell-secreted endothelial-cell-retraction factor
25. c-erbB2/neu over-expression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties
26. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro
27. Retraction of cultured endothelial cell monolayer by human breast cancer cells, MCF-7
28. Effects of gamma irradiation on cultured rat and mouse microvessel endothelial cells: Metastatic tumor cell adhesion, subendothelial matrix degradation, and secretion of tumor cell growth factors